BioVie Inc.

BIVI · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$17,542-$32,121-$50,256-$26,084
Dep. & Amort.$229$229$229$229
Deferred Tax$0$0-$1,033,455$0
Stock-Based Comp.$2,472$0$6,375$6,194
Change in WC-$4,396-$87-$270$2,751
Other Non-Cash$212$4,033$1,037,124-$2,081
Operating Cash Flow-$19,025-$27,945-$40,253-$18,991
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$14,301$0
Inv. Sales/Matur.$0$14,525$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$14,525-$14,301$0
Financing Activities
Debt Repay.-$5,850-$10,000$0$14,610
Stock Issued$15,675$27,803$55,371$18,511
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2,901$0$2$0
Financing Cash Flow$12,726$17,803$55,373$33,121
Forex Effect$0$0$0$0
Net Chg. in Cash-$6,299$4,383$819$14,130
Supplemental Information
Beg. Cash$23,844$19,461$18,642$4,512
End Cash$17,545$23,844$19,461$18,642
Free Cash Flow-$19,025-$27,945-$40,253-$18,991